Javascript must be enabled to continue!
Clinical and Echocardiographic Determinants of Long-Term Survival After Surgical Myectomy in Obstructive Hypertrophic Cardiomyopathy
View through CrossRef
Background—
Surgical myectomy has been the standard treatment for patients with drug-refractory obstructive hypertrophic cardiomyopathy. The clinical and echocardiographic predictors of long-term survival and freedom from cardiovascular morbidity after myectomy have been unclear.
Methods and Results—
We studied a consecutive cohort of 338 adult patients (age at operation 47±14 [range 18 to 77] years, 60% male) who underwent myectomy at our institution. Preoperative resting left ventricular outflow tract (LVOT) gradient was 66±32 mm Hg (range 5 to 158 mm Hg). Early postoperative mortality was 1.5% (5 deaths): 4 deaths occurred between 1978 and 1992, and 1 death occurred between 1993 and 2002. During long-term follow-up, 83% of patients reported an improvement to functional class I or II. The majority of patients (98%) had no resting LVOT gradient. Long-term survival was excellent, with 98±1% survival at 1 year, 95±1% at 5 years, and 83±3% at 10 years after myectomy. Multivariable Cox regression analysis identified 5 predictors of overall mortality: (1) age ≥50 years at surgery (hazard ratio [HR] 2.8, 95% CI 1.5 to 5.1,
P
=0.001), (2) female gender (HR 2.5, 95% CI 1.5 to 4.3,
P
=0.0009), (3) history of preoperative atrial fibrillation (HR 2.2, 95% CI 1.2 to 4.0,
P
=0.008), (4) concomitant CABG (HR 3.7, 95% CI 1.7 to 8.2,
P
=0.001), and (5) preoperative left atrial diameter ≥46 mm (HR 2.9, 95% CI 1.6 to 5.4,
P
=0.0008). Significant predictors of late major cardiovascular events found on multivariable analysis were (1) female gender (HR 3.3, 95% CI 2.0 to 5.4,
P
<0.0001), (2) history of preoperative atrial fibrillation (HR 1.9, 95% CI 1.1 to 3.3,
P
=0.02), and (3) preoperative left atrial diameter ≥46 mm (HR 2.5, 95% CI 1.5 to 4.3,
P
=0.0008).
Conclusions—
Myectomy provides excellent relief for LVOT obstruction in patients with hypertrophic cardiomyopathy. Preoperative clinical and echocardiographic variables can predict long-term outcome after myectomy.
Ovid Technologies (Wolters Kluwer Health)
Title: Clinical and Echocardiographic Determinants of Long-Term Survival After Surgical Myectomy in Obstructive Hypertrophic Cardiomyopathy
Description:
Background—
Surgical myectomy has been the standard treatment for patients with drug-refractory obstructive hypertrophic cardiomyopathy.
The clinical and echocardiographic predictors of long-term survival and freedom from cardiovascular morbidity after myectomy have been unclear.
Methods and Results—
We studied a consecutive cohort of 338 adult patients (age at operation 47±14 [range 18 to 77] years, 60% male) who underwent myectomy at our institution.
Preoperative resting left ventricular outflow tract (LVOT) gradient was 66±32 mm Hg (range 5 to 158 mm Hg).
Early postoperative mortality was 1.
5% (5 deaths): 4 deaths occurred between 1978 and 1992, and 1 death occurred between 1993 and 2002.
During long-term follow-up, 83% of patients reported an improvement to functional class I or II.
The majority of patients (98%) had no resting LVOT gradient.
Long-term survival was excellent, with 98±1% survival at 1 year, 95±1% at 5 years, and 83±3% at 10 years after myectomy.
Multivariable Cox regression analysis identified 5 predictors of overall mortality: (1) age ≥50 years at surgery (hazard ratio [HR] 2.
8, 95% CI 1.
5 to 5.
1,
P
=0.
001), (2) female gender (HR 2.
5, 95% CI 1.
5 to 4.
3,
P
=0.
0009), (3) history of preoperative atrial fibrillation (HR 2.
2, 95% CI 1.
2 to 4.
0,
P
=0.
008), (4) concomitant CABG (HR 3.
7, 95% CI 1.
7 to 8.
2,
P
=0.
001), and (5) preoperative left atrial diameter ≥46 mm (HR 2.
9, 95% CI 1.
6 to 5.
4,
P
=0.
0008).
Significant predictors of late major cardiovascular events found on multivariable analysis were (1) female gender (HR 3.
3, 95% CI 2.
0 to 5.
4,
P
<0.
0001), (2) history of preoperative atrial fibrillation (HR 1.
9, 95% CI 1.
1 to 3.
3,
P
=0.
02), and (3) preoperative left atrial diameter ≥46 mm (HR 2.
5, 95% CI 1.
5 to 4.
3,
P
=0.
0008).
Conclusions—
Myectomy provides excellent relief for LVOT obstruction in patients with hypertrophic cardiomyopathy.
Preoperative clinical and echocardiographic variables can predict long-term outcome after myectomy.
Related Results
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct
Introduction
Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
Extended Myectomy for Apical Hypertrophic Cardiomyopathy: A Case Report
Extended Myectomy for Apical Hypertrophic Cardiomyopathy: A Case Report
Abstract
BackgroundApical hypertrophic cardiomyopathy is a variant of hypertrophic cardiomyopathy that predominantly affects the left ventricle apex and rarely involves the...
Midterm Outcome of Septal Myectomy for Hypertrophic Obstructive Cardiomyopathy (HOCM): A Single-Center Observational Study
Midterm Outcome of Septal Myectomy for Hypertrophic Obstructive Cardiomyopathy (HOCM): A Single-Center Observational Study
Background: For years, septal myectomy has been considered the best available treatment for hypertrophic cardiomyopathy. In Bangladesh, however, this technique is only nascent. We ...
Comparative Analysis of the Coronary Arteries Flow Pattern in Secondary Myocardial Hypertrophies and by Sarcomeric Mutation
Comparative Analysis of the Coronary Arteries Flow Pattern in Secondary Myocardial Hypertrophies and by Sarcomeric Mutation
Background: Coronary flow with a diastolic predominance increases two to five times in hyperemia, mediated by vasodilation (coronary flow reserve, CFR) and, in hypertrophy, relativ...
Current management of hypertrophic cardiomyopathy
Current management of hypertrophic cardiomyopathy
ABSTRACT
Hypertrophic cardiomyopathy is a common yet under-recognized genetic structural heart condition characterized by left ventricular hypertrophy. Patients m...
Abstract 17060: Effect of Septal Myectomy on Obstructive Sleep Apnea Syndrome in Patients With Hypertrophic Obstructive Cardiomyopathy
Abstract 17060: Effect of Septal Myectomy on Obstructive Sleep Apnea Syndrome in Patients With Hypertrophic Obstructive Cardiomyopathy
Introduction:
Hypertrophic cardiomyopathy (HCM) has a higher prevalence of OSA. The impact of obstructive sleep apnea on perioperative complications in hypertrophic obs...
Differentiation of Cardiac Amyloidosis and Hypertrophic Cardiomyopathy
Differentiation of Cardiac Amyloidosis and Hypertrophic Cardiomyopathy
ABSTRACT. Eriksson P, Backman C, Eriksson A, Eriksson S, Karp K, Olofsson B‐O (Departments of Internal Medicine, Geriatric Medicine, and Clinical Physiology, University Hospital, ...
A Case of Takotsubo Cardiomyopathy Following Postpartum Hemorrhage in a Patient with Concurrent Influenza A
A Case of Takotsubo Cardiomyopathy Following Postpartum Hemorrhage in a Patient with Concurrent Influenza A
Background
Takotsubo cardiomyopathy, also known as stress cardiomyopathy and broken heart syndrome, is a transient, non-ischemic cardiomyopathy marked by revers...

